RIVERSIDE WALTER REED — History
CCN 490130 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$108M
Latest Revenue (FY2022)
+18.3%
Revenue CAGR (3yr)
12.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $77M | $95M | $108M | +13.6% | +18.3% |
| Operating Expenses | $71M | $83M | $95M | +14.4% | +15.5% |
| Operating Margin | 8.3% | 13.2% | 12.5% | -4.8% | +23.2% |
| Net Income | $6M | $13M | $14M | +8.1% | +45.8% |
| Licensed Beds | 67 | 67 | 67 | +0.0% | +0.0% |
| Total Patient Days | 8,817 | 10,373 | 9,408 | -9.3% | +3.3% |
| Medicare Day % | 55% | 48% | 44% | -9.1% | -10.5% |
| Medicaid Day % | 2% | 1% | 2% | +4.5% | -9.5% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +40.0% ($77M → $108M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+18.3%
This Hospital
+7.6%
State Avg
Latest Margin
12.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $124M | 14.7% |
| FY2024 (proj) | $139M | 16.8% |
| FY2025 (proj) | $155M | 18.9% |